*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| ICD Code | ICD Description | Total National Projected Hospitalizations - Annualized (Present on Admission - All) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | Total Medicare Hospitalization after Exclusion | Avg. LOS | Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment Per Day | Payment Per Hospitalization | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T380X5A | Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 18.33 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| ICD Code | ICD Description | Total National Projected Hospitalizations - Annualized (Present on Admission - All) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | Total Medicare Hospitalization after Exclusion | Avg. LOS | Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment Per Day | Payment Per Hospitalization | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T380X5A | Adverse effect of glucocorticoids and synthetic analogues, initial encounter | 6.59 | 28.19 | ||||||||||||||||
| T380X5D | Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter | 10.9 | 26.29 | ||||||||||||||||
| T380X5S | Adverse effect of glucocorticoids and synthetic analogues, sequela | 7.86 | 29.49 |